CWM
EXAS

C2C Wealth Management’s Exact Sciences EXAS Stock Holding History

C2C Wealth Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,020
Closed -$204K – 195
2022
Q1 		$204K Sell
3,020
-300
-9% -$21.9K 0.03% 194
2021
Q4 		$258K Buy
+3,320
New +$293K 0.04% 184

Other funds holding EXAS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

C2C Wealth Management's EXAS Position: Q2 2022 in Review

C2C Wealth Management sold out of Exact Sciences (EXAS) in Q2 2022, closing a stake of 3,020 shares — an estimated $204K sold.

C2C Wealth Management first reported a position in EXAS in Q4 2021 and held it in 2 quarters. The position peaked at $258K in Q4 2021. 501 funds tracked by Wall St. Rank hold EXAS as of Q2 2022.

  • C2C Wealth Management reported no remaining Exact Sciences position as of Q2 2022 after selling out during the quarter.
  • C2C Wealth Management sold 3,020 Exact Sciences shares in Q2 2022, an estimated $204K.
  • C2C Wealth Management first reported a position in Exact Sciences in Q4 2021 and held it in 2 quarters.
  • C2C Wealth Management's Exact Sciences position peaked at $258K in Q4 2021.
  • 501 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2022.

Based on C2C Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.